(Q44795394)
Statements
A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed (English)
Mario Del Tacca
Giacomo Allegrini
Gianluca Masi
Cecilia Barbara
1 March 2004